Only 5% of all bladder cancers are squamous cell carcinomas (SCCs) [4] characterized by low frequent alterations of ERBB genes but frequent TP53 mutations, while alterations of the FGFR3 gene are rare but associated with worse patients’ outcome [5,6]. This evidence concerns the gene FGFR3 and urinary bladder cancer.